Allergy and Asthma Proceedings

Article	Citations
For the Patient	77
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	71
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	41
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	32
Impact of steroids on the immune profiles of children with asthma living in the inner-city	32
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	30
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	29
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	25
COVID-19 in Italian children and adolescents: The role of allergy and asthma	23
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	22
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	20
Venom allergen immunotherapy	20
For the patient	19
Operationalizing shared decision making in clinical practice	19
Future directions in allergen immunotherapy	19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	19
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	18
For the Patient	18
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma	18
For the Patient	17
The influence of sea breeze on mold spore dispersion	17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16
For the Patient	16
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	16

Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	16
Evaluation and management of chronic cough in adults	16
Treatment strategies for postviral olfactory dysfunction: A systematic review	15
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	15
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	14
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	14
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	13
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	13
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	13
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
For the Patient	12
Diagnostic utility of basophil CD203c expression in β-lactam allergy	12
Evaluation of the peripheral blood eosinophil count as a predictor for fractional exhaled nitric oxide or bronchodilator reversibility test outcome	11
For the Patient	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
Studies of mitochondrial and nuclear DNA released from food allergen‐activated neutrophils. Implications for non‐IgE food allergy	11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
For the patient	10
Guidelines for management of hereditary angioedema: What is new? What is missing?	10
Effects of mechanical washing and drying on the removal of pet allergens	10
Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood	10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	10
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	10
Effect of COVID-19 on hereditary angioedema activity and quality of life	9
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	9
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	9
Paucigranulocytic asthma: Do sputum macrophages matter?	8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	8
Clinical features of anaphylaxis in children	8
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	8
Benralizumab in the management of rare primary eosinophilic lung diseases	8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	8
The long COVID syndrome: A conundrum for the allergist/immunologist	8
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist	8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	8
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	8
Assessing cross-reactivity in allergen immunotherapy	7
The association of timothy grass allergy and cat ownership on cat sensitization	7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	7
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	7
Treatment options for chronic rhinosinusitis with nasal polyps	7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	7

Overview of secondary immunodeficiency	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	7
Food-induced anaphylaxis in early childhood and factors associated with its severity	7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	7
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	7
Curcumin does not significantly affect immediate skin tests	6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	6
For the Patient	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida	6
A masquerade of recurrent anaphylaxis	6
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	6
Is nutraceutical supplementation appropriate for COVID-19 management?	5
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	5
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination	5
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	5
Caregivers’ role in managing hereditary angioedema and perceptions of treatment-related burden	5
The COVID-19 impact on severe uncontrolled asthma costs and biologic use	5
Treatment options for moderate to severe atopic dermatitis	5
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	5
Genetically-determined defects of T cell development	5
Immunodeficiency: Burden of Illness	5
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	5
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	5
Cat allergy in children and the effect of the COVID-19 pandemic	5
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies	5
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors	5
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience	5
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	5
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	5
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications	5
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	5
For the patient	5
The immunologic response to severe acute respiratory syndrome coronavirus 2	5
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease	5
A review of allergen immunotherapy in asthma	5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	5
Anaphylaxis: Long-term management and resources	5
Atopic dermatitis: Best of guidelines and yardstick	4
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?	4
Successful rapid liposomal amphotericin B desensitization in pediatric case series	4
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study	4
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment	4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	4
For the patient	4
Peptide immunotherapy for aeroallergens	4
Persistent airflow obstruction in inner-city children with asthma	4
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines	4
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema	4
For the Patient	4
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	4
Management and referral patterns for new-onset chronic cough in primary care patients	4
Effect of prenatal phthalate exposure on childhood atopic dermatitis: A systematic review and meta-analysis	4
Idiopathic anaphylaxis: Diagnosis and management	4
Clinical implications of asthma endotypes and phenotypes	4
Integrating innovation and shared decision-making in allergy and immunology practice	4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	4
Allergy immunotherapy for allergic fungal respiratory diseases	3
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies	3
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency	3
For the patient	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Health disparities investigated in a primary care penicillin allergy removal pathway	3
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications	3
Assessment of mask use on oxygen saturation in adults and children with asthma	3
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	3
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis	3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	3

Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	3
Accelerated/rush allergen immunotherapy	3
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose	3
Allergic comorbidities in fibromyalgia	3
The complexities of allergic diseases continue to challenge the allergist-immunologist	3
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance	3
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis	3
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist	3
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub	3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings	3
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation	3
Capturing total steroid burden in patients with atopic dermatitis and asthma	3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing	3
Oral immunotherapy with sunflower seed butter and a review of seed allergy	3
The effect of the socioeconomic status on the measurement of asthma control	3
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches	3
The utility of shared decision making in the management of hereditary angioedema	3
Persistent urticarial rash in a newborn	3
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis	2
Eosinophilic esophagitis: from discovery to effective treatment	2
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children	2
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida	2
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study	2
Current and emerging therapies for eosinophilic esophagitis	2
COVID-19: A continuing challenge for the allergist/immunologist	2
Pediatric sublingual allergen immunotherapy	2
For the Patient	2
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes	2
The challenge of neurologic disease for the allergist/immunologist	2
Health disparities in hymenoptera venom allergy management	2
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia	2
Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population	2
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience	2
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)	2
Evaluation and management of adverse reactions to the COVID-2019 vaccines	2
To test or not to test: Lessons learned from screening infants for peanut allergy	2
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist	2
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema	2
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist	2
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis	2
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities	2
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study	2
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD	2
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease	2
Prognosis of food-induced anaphylaxis in children: A single-center real-life study	2
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency	2
Real world use of peanut component testing among children in the Chicago metropolitan area	2
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management	2
The relationship between childhood atopic dermatitis and asthma in an under resourced community	2
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	2
Do commercial dog extracts cross-react with Felis domesticus allergen 1	2
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure	2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS	2
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up	2
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts	2
Review of efficacy of ciclesonide for the treatment of asthma in children	2
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts	2
Idiopathic non-mast cell angioedema: Treatment insights from global experts	2
Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores	2
Immunodeficiency: Complement disorders	2